NVELOP Trademark

pharmaceutical preparations for gene therapy and gene editing; drug delivery agents that facilitate delivery of pharmaceuticals, namely, drug delivery agents consisting of particles in the nature of virus-like particles that facilitate delivery of a wide range of pharmaceuticals; drug carriers for medical use, namely, drug delivery agents in the form of engineered particles in the nature of virus-like particles that facilitate the delivery of pharmaceutical preparations for delivering drugs to human organs; cell and gene therapy products for increasing protein expression in cells, namely, engineered virus-like particles; pharmaceutical and biological preparations for delivering proteins into cells for the prevention, diagnosis and treatment of genetic diseases, namely, cancer, including hematological and solid tumors, autoimmune diseases, cardiovascular disease, respiratory disease, pulmonary disease, central nervous system diseases and disorders, mitochondrial diseases and disorders, endocrine disorders, gastrointestinal diseases, auditory processing disorders (APD) and hearing loss disorders, inflammatory diseases, acquired and innate immunodeficiencies, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, brain disorders and diseases, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; pharmaceutical and biological preparations for delivering therapeutic proteins for treatment of cancer, including hematological and solid tumors, autoimmune diseases, cardiovascular disease, respiratory disease, pulmonary disease, central nervous system diseases and disorders, mitochondrial diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, auditory processing disorders (APD) and hearing loss disorders, inflammatory diseases, acquired and innate immunodeficiencies, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, brain disorders and diseases, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes

medical and scientific research in the fields of gene therapy, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, cell therapy, therapeutic proteins, protein expression, protein delivery and drug delivery; services in the field of production of cell therapies namely, scientific research and medical research in the field of gene editing technology featuring gene-editing and protein delivery; pharmaceutical research services; pharmaceutical drug development services; medical and scientific research for the treatment of genetic diseases and disorders